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The formation of endocardial cushions in the atrioventricular (AV) canal of the rudimentary heart requires epithelial-to-
mesenchymal cell transformation (EMT). This is a complex developmental process regulated by multiple extracellular
signals and transduction pathways. A collagen gel assay, long used to examine endocardial cushion development in avian
models, is now being employed to investigate genetically engineered mouse models with abnormal heart morphogenesis. In
this study, we determine interspecies variations for avian and mouse cultured endocardial cushion explants. Considering
these observed morphologic differences, we also define the temporal requirements for TGF2 and TGF3 during mouse
endocardial cushion morphogenesis. TGF2 and TGF3 blocking antibodies inhibit endothelial cell activation and
transformation, respectively, in avian explants. In contrast, neutralizing TGF2 inhibits cell transformation in the mouse,
while TGF3 antibodies have no effect on activation or transformation events. This functional requirement for TGF2
is concomitant with expression of TGF2, but not TGF3, within mouse endocardial cushions at a time coincident
with transformation. Thus, both TGF2 and TGF3 appear necessary for the full morphogenetic program of EMT in
the chick, but only TGF2 is expressed and obligatory for mammalian endocardial cushion cell transformation.
© 2002 Elsevier Science (USA)
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The high incidence of structural heart defects highlights
the complexity of cardiac development (Hoffman, 1995).
The morphogenetic process of endocardial cushion trans-
formation and invasion that occurs in the atrioventricular
canal and outflow tract of the rudimentary heart is critical
for normal valve development and cardiac septation leading
to a mature, four-chambered heart.
The process of endocardial cushion transformation dem-
1 To whom correspondence should be addressed. Fax: (480) 301-
7017. E-mail: Camenisch.todd@mayo.edu.
170onstrates temporal and spatial specificity within the em-
bryonic heart tube. Initially, an acellular extracellular ma-
trix (cardiac jelly) separates the myocardial and endothelial
layers of the primitive heart tube. In the atrioventricular
(AV) canal and outflow tract regions of the heart, endocar-
dial cushions form as the result of an expansion of extra-
cellular matrix rich in hyaluronan and chondroitin sulfate
proteoglycans. At a specific time in development, induc-
tive signals derived from the myocardium activate endothe-
lial cells in these regions to undergo an epithelial-to-
mesenchymal transformation (EMT). Cell transformation
within the endocardial cushions occurs as a subset of
endothelial cells hypertrophy, disengage cell–cell adhe-
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sions, extend filopodia, and invade the extracellular matrix
(Markwald et al., 1979). Invading mesenchymal cells within
the endocardial cushions contribute to the formation of the
mitral and tricuspid valve leaflets and complete atrial and
ventricular septation (Eisenberg and Markwald, 1995). This
cardiac morphogenetic process is unique within the endo-
cardial cushions, as adjacent atrial or ventricular endothelia
fail to undergo transformation in vivo and do not appear to
possess the capacity to transform in vitro even when
exposed to appropriate inductive stimuli (Runyan and
Markwald, 1983).
Progress in understanding the molecular regulation of AV
canal development has been facilitated by an in vitro
three-dimensional collagen gel culture system. Bernanke
and Markwald (1979) developed an in vitro model of cardiac
mesenchyme formation utilizing a hydrated type I collagen
gel matrix. Subsequently, Runyan and Markwald (1983)
modified this assay to demonstrate temporal correlation to
in vivo events, regional specification within endocardial
cushion tissues, and a dependence of this process on induc-
tive signals from the cushion myocardium.
TGF2 and TGF3 are expressed in the endocardial
cushions of avian embryos prior to transformation events
and following EMT, while TGF1 has not been detected. In
addition, distinct functional roles for both TGF2 and
TGF3 (Boyer et al., 1999; Nakajima et al., 1994; Potts et
al., 1991) and their cognate TGF receptors (Boyer and
Runyan, 2001; Brown et al., 1996, 1999) have been eluci-
dated by using the in vitro assay with avian endocardial
cushion tissue. TGF2 signaling appears to mediate AV
canal endocardial cell activation and separation, while
TGF3 is obligatory for mesenchymal cell formation and
invasion into the underlying matrix. In the developing
mouse, however, apparent conflicting data have been re-
ported concerning the requirements of TGF molecules
during endocardial morphogenesis. Mouse embryos defi-
cient for TGF1 or TGF3 do not have cardiac phenotypes
(Letterio and Roberts, 1996; Sanford et al., 1997), and while
AV endocardial cushion morphogenesis is abnormal in
TGF2/ embryos, the most significant cardiac phenotype
is attributed to disrupted outflow tract development (San-
ford et al., 1997). These data suggest that there are different
TGF requirements during avian and mouse endocardial
cushion morphogenesis.
To further explore the roles of TGF2 and TGF3 in
mammalian cardiac valve development and to determine
interspecies variation in the in vitro collagen gel invasion
assay, we executed parallel studies with mouse and chick
endocardial cushion tissues. Substantial interspecies differ-
ences were identified between avian and mouse AV canal
explants which may be attributed to distinct growth factor
requirements. In this regard, we determined that TGF
ligands do not have the same specificity on AV canal
morphogenesis during mouse development as they do dur-
ing avian development. Only TGF2 has a developmental
role in mouse AV endocardial transformation into mesen-
chyme that is independent of TGF3.
EXPERIMENTAL PROCEDURES
Embryo Isolation and Staging
Mouse and chick embryos were dissected free of decidua and
embryonic membranes in 4°C sterile 1 Tyrode’s salt buffer and
staged in a standard manner for avian Hamburger and Hamilton
stages (Hamburger, 1992) and mouse (Kaufman and Bard, 1999).
Two independent observers using a dissecting stereo microscope
manually counted somites. Somite count and developmental stage
of embryos are shown comparatively in Table 1. Embryos were
used for in vitro analysis as described below.
AV Canal Endocardial Cushion Morphogenesis
Assay
Fertilized White Leghorn chicken eggs (Rosemary’s Farm, Santa
Clara, CA) were incubated at 37°C for 48–72 h to obtain embryo
stages encompassing the initial formation of the acellular endocar-
dial cushion (St. 12) to the appearance of a large population of
mesenchymal cells within the cushions (St. 18). Embryonic hearts
were removed and the AV endocardial cushions regions dissected
apart from the adjacent atria and ventricular chambers. The AV
canal was opened longitudinally to expose the inner endocardial
surface. AV canals were placed endothelial surface down onto
hydrated type I collagen gels and allowed to attach for 6 h according
to published procedures (Potts et al., 1991). M199 media (Gibco/
BRL, Rockville, MD), supplemented with 0.01% insulin, trans-
ferrin, and selenium (ITS) (Gibco/BRL) and 1% chick serum (Gibco/
BRL) served as culture medium. Explants were cultured for 48 h at
TABLE 1
Interspecies Comparison of Developmental Stage
and Somite Number
Chick Mouse
Stage (HH) Somite number Stage (dpc) Somite number
12 16 8 4
13 19 8.5 10–13
14 22 9 17
15 24–27a 9.5a 21–26
16a 26–28 10a 26–29b
17 29–32b 10.5 30–34
18 32–36 11 34
Note. Because embryos develop at different rates under the same
incubation conditions or within the same litter, somite number
was utilized as an additional method for comparing mouse and
chick embryos.
a AV endocardial cushion transformation observed in vivo be-
tween 21–28 somites for mouse and 25–28 for chick.
b Formation of endothelial cell monolayer at higher somite
number at this stage.
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37°C, 5% CO2 prior to determining the extent of endocardial
migration or spread and mesenchymal cell invasion by using
Hoffman phase microscopy as previously described (Runyan and
Markwald, 1983). Briefly, the criteria used for endocardial cell
migration was the appearance of rounded, polygonal cells on the
collagen gel surface. The primary morphologic criteria for mesen-
chymal cells invasion was the appearance of cells with character-
istic stellate appearance within the gel matrix (Runyan and Mark-
wald, 1983).
Mouse AV canal “explants” from wild-type FVB mouse embryos
were isolated as described from timed fertilized female mice and
somite number verified embryonic age. Experimental conditions
were optimized for mouse endocardial cushion cultures to obtain
similar morphologic events compared with the established avian
system. Briefly, M199 media was consistently used for gel casting
in four-well microculture dishes (Nalge Nunc, Naperville, IL).
However, substituting OPTI- MEM media (Gibco/BRL) plus 0.01%
ITS (Gibco/BRL) to hydrate the polymerized type I collagen gels
before mouse explant placement provided reproducible cultures
with minimal supplements (Camenisch et al., 2000). Mouse tissues
required 12 h for attachment to the collagen gel surface at 37°C, 5%
CO2 prior to the application of 0.1 ml of M199 supplemented with
1% fetal calf serum (Hyclone, Logan, UT), 50 U/ml penicillin and
50 g/ml streptomycin, and 0.01% ITS (Gibco/BRL). Explants were
cultured at 37°C, 5% CO2 for 48 h. Table 2 details the differences
in culture conditions between the two species.
Antibody Treatments
Stage 15/16 chick and E9.5 mouse endocardial cushion explants
(AV canal and outflow tract) were allowed to attach to the collagen
gel matrix as described. M199 media was supplemented with either
10 l antibody to TGF3 (D3) (Developmental Studies Hybridoma
Bank), antibody to TGF2 (1 g/ml) (R&D Systems, Minneapolis,
MN), or isotype control IgG or IgM (0.25 mg/ml). The anti-TGF2
antibody has less than 2% cross-reactivity to other TGF mol-
ecules (R&D Systems). Epitope mapping of the anti-TGF3 anti-
body recognizes the identical seven-amino-acid peptide sequence
(RALDTNY) common to human and mouse isoforms (Boyer et al.,
1999). Explants were cultured in the continued presence of indi-
cated antibody for 48 h. Independent experiments were repeated a
minimum of three times. Transformation of endothelium to mes-
enchyme and invasion into the collagen gel was imaged by using
Hoffman optics as described above.
In Situ Hybridization
Mouse embryos were removed from decidua and fixed in 4%
paraformaldehyde (PFA) in phosphate-buffered saline (0.1 M; pH
7.2). Fixed embryos were dehydrated in graded ethanol and xylene
and embedded in paraffin. Serial 5-m sections were mounted onto
TESPA-coated (Sigma, St. Louis, MO) glass slides. A 442-bp EcoRI/
XhoI TGF2-cDNA fragment cloned into Sp72 (kindly provided by
T. Doetschman) was linearized with XhoI or EcoRI and transcribed
with T7 or SP6 RNA-polymerase to obtain sense and anti-sense
35S-labeled riboprobes, respectively. A 609-bp SmaI/EcoRI, TGF3-
cDNA fragment cloned into pGEM7zf (kindly provided by Dr.
H.L. Moses, Vanderbilt University) was linearized with XbaI or
HindIII and transcribed with SP6 or T7 RNA polymerase to obtain
sense and antisense probes, respectively.
In situ hybridization was performed on PFA-fixed tissue sections
as described by Hierck et al. (1996). After hybridization, sections
were dehydrated in graded ethanol, air-dried, coated with Ilford G5
emulsion (ILFORD Ltd, Mobberly, England), and exposed for 14
days at 4°C. Following exposure, slides were developed in Kodak
D19 developing solution (Kodak, Chalon s. Saone, France) for 4 min
at room temperature, rinsed in distilled water, and fixed in Ilford
Hypam fixative (ILFORD Ltd). Sections were counterstained with
Mayer’s hematoxylin, dehydrated, and mounted with Malinol
(SCHMID&CO, Stuttgart-Untertu¨rkheim, Germany) prior to light
microscopic examination.
Immunohistochemistry
Deparaffinized sections were briefly rinsed in PBS, followed by
15 min of treatment with 0.3% H2O2 in PBS. Sections were
incubated overnight with primary antibody to -smooth muscle
actin (HHF-35) (DAKO A/S, Glostrup, Denmark) diluted 1:500 in
PBS with 0.05% Tween 20 and 1% BSA at room temperature.
Sections were thoroughly rinsed followed by incubation with
horseradish peroxidase-conjugated rabbit anti-mouse antibody
(1:200, 1.5 h, DAKO A/S) followed by goat-anti-rabbit immuno-
TABLE 2
Experimental Conditions for Chick and Mouse Endocardial Cushion Explant Cultures
Chick Mouse
Gel casting (R T for 30 min) Type I collagen (1 mg/1 ml)
100 l 10 M199
100 l 2.2%(wt/vol) NaHCO3
300 l per 12 mm well
No modifications
Gel hydration (37°C, 5% CO2
for at least 30 min)
300 l M199 containing 1% chick
serum, ITS, PS
300 l OPTI-MEM
1% fetal calf serum, ITS, PS
Explant attachment Remove media prior to placement.
Incubate 6 h at 37°C, 5% CO2
Remove media prior to placement.
Incubate 12 h at 37°C, 5% CO2
Explant culture Add 300 l supplemented M199.
Culture 48 h at 37°C, 5% CO2
100 l M199 supplemented with 1% fetal calf serum, ITS, PS.
Culture 48 h at 37°C, 5% CO2
Note. ITS, insulin, transferrin, and selenium; PS, penicillin streptomycin.
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globulin (1:50, 1.5 h, DAKO A/S), rabbit-peroxidase-anti-peroxidase
(1:500, 1.5 h, DAKO A/S), and subsequent treatment with 0.04%
diaminobenzidine tetrahydrochloride/0.06% H2O2 in 0.05 M Tris–
Maleic acid (pH 7.6) for 10 min at room temperature. Sections were
briefly counterstained with Mayer’s hematoxylin, dehydrated, and
mounted with Entellan (Merck, Darmstadt, Germany).
RESULTS
Morphologic Assessment and in Vitro Comparison
Variation between chronological age and gestational/
developmental age during embryogenesis is well recognized
for incubated chick embryos and within mouse litters
(Kaufman and Bard, 1999). Somite number was therefore
utilized as an additional method for comparing develop-
mental stages between species. Detailed staging of em-
bryos, focused upon the appearance of phenotypic mesen-
chymal cells within the AV endocardial cushions,
demonstrated that cushion cell transformation occurs at
approximately St. 16/17 in the chick and E9.5 in the
mouse. These morphologic stages encompass a range of
somites (Table 1). The most consistent external measure for
AV endocardial cushion transformation was the attainment
of 26 (1) somites in either species. Cell transformation
within the outflow tract endocardial cushions appeared
delayed by approximately 1 day in the mouse and one to
two stages in the chick. Somite staging was used to verify
embryonic age for direct comparisons of TGF expression
patterns as well as analysis of functional data from parallel
endocardial cushion explant cultures.
Direct comparisons of endocardial cushion explants cul-
tured in vitro revealed important morphologic differences
between mouse and chick tissues (Fig. 1). In avian AV canal
explants, endothelial cells initially leave the explant and
spread over the collagen gel surface as a monolayer prior to
transformation in ovo (Runyan and Markwald, 1983). This
activation step results in loss of cell–cell junctions and
separation between adjacent cells. A subset of these cells
subsequently extends pseudopodia and transforms into a
mesenchymal cell phenotype capable of migration on and
into the gel matrix (Figs. 1E and 1F). In contrast, mouse AV
canal explant cultures established prior to EMT fail to
display a clearly defined endothelial monolayer (Figs. 1A
and 1B). Endothelial cell–cell separation, “activation,” is
not readily apparent in mouse AV canal explants. Rather,
the mouse cardiac endothelia appear to transform directly,
exhibiting characteristic mesenchymal morphology and in-
vasive capability in close proximity to the primary explant
(Fig. 1B). Cultured AV canal endocardial cushions isolated
from chick or mouse embryos that had already undergone
cell transformation in vivo (somite number 28 or greater)
appear more similar. For these later developmental stages,
AV canal explants from both species display an expansion
of endothelial cells over the collagen gel and decreased
mesenchymal cell formation and invasion (Figs. 1C, 1D,
and 1H). Collectively, these observations define the tempo-
ral specificity of EMT during both chick and mouse AV
canal morphogenesis in vitro (Table 1).
FIG. 1. In vitro analysis of endocardial cushion morphogenesis
reveals important differences between mouse and chick AV canal
explants. Mouse AV canal explants cultured through the period of
in vivo transformation fail to display clearly defined endothelial
cell spread over the collagen gel surface or cell–cell separation;
invasive mesenchyme appear in close proximity to the explant site,
suggesting an immediate transformation (A, B). Chick AV canal
explant culture from similar stages demonstrates characteristic
endothelial cell spread, cell–cell separation, and the appearance of
transformed mesenchymal cells concentrated at the periphery of
the endothelial sheet (E, F). “Post-transformation” AV canal ex-
plants exhibit a significant endothelial expansion over the gel
surface for both the mouse (C, D) and chick (G, H). The mouse
endothelial sheet in later staged explants does not display cell–cell
separation evident in the chick explants. Scale bar, 45 m.
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Expression of TGF2 and TGF3 during Mouse AV
Canal Formation
The peptide growth factors TGF2 and TGF3 are both
expressed in the avian endocardial cushions (Boyer et al.,
1999) and have distinct roles during EMT, but it is unclear
whether they play similar requisite functions during mouse
AV canal morphogenesis. The expression of both TGF2
and TGF3 was examined during the critical developmental
period encompassing valvular formation, from E9.0–E13.0.
Expression of TGF3 could not be detected within the time
span of endocardial cushion development and associated
epithelial–mesenchyme transformation in the mouse em-
bryo (E9.0–E10.0) (Figs. 2C and 2F). Expression of TGF3
within the endocardial cushions was only detected after
E11.0 (Fig. 3C), once mesenchymal cells have already in-
vaded the matrix and the atrial septum has connected with
the AV cushion tissue. In contrast, TGF2 is highly ex-
pressed at E9.0–E10.0 in the myocardium lining the endo-
cardial cushions (Figs. 2B and 2E) and persisted beyond
E12.0 (Fig. 3B). The endothelium-derived mesenchymal
cells, which begin to populate the AV endocardial cushions
between E9.0 and E10.0, are TGF2-positive (yellow arrow,
Fig. 2E). The dorsal mesocardium also highly expresses
TGF2 at E10.0. The endocardium of mouse AVC cushions
appears to express TGF2 but not TGF3. Expression of
TGF2 becomes enhanced over the next 3 days of cushion
development concomitant with the increased number of
mesenchymal cells that populate the cushions and subse-
quent remodeling into functional valves (Fig. 3). Thus,
TGF2 is expressed in the mouse cushion myocardium as
well as in the invading mesenchymal cells during AV canal
morphogenesis. These data show that TGF2, but not
TGF3, is strongly expressed in the early cardiac endocar-
dial cushions, and suggest that TGF2 is the key growth
factor directing EMT within the mouse AV canal.
TGF2 and TGF3 Functions during in Vitro
Endocardial Cushion Morphogenesis
Our in situ hybridization results concentrating on the
E10–E12 mouse heart are consistent with previous TGF
isoform expression studies (Dickson et al., 1993). Com-
bined with the primary phenotypes of the TGF-deficient
animal models, these data suggest that TGF2, but not
TGF3, has a role during EMT in the mouse. Specific
neutralizing antibodies to TGF2 and TGF3 were there-
fore utilized in the collagen gel assay to compare the impact
these growth factors have on the transformation of cardiac
endothelium into invasive mesenchyme in mouse and
avian endocardial cushions.
TGF2 blocking antibody inhibits endothelial cell–cell
separation and decreased mesenchymal cell invasion as
previously reported in avian explant cultures (Fig. 4B)
(Boyer et al., 1999). Similarly, neutralization of TGF2
abated phenotypic transformation in mouse AV canal ex-
plants, (Fig. 4A). In striking contrast to the immediate
transformation observed in naı¨ve E9.5 mouse endocardial
FIG. 2. Expression of TGF2 and TGF3 in E10.0 mouse embryos. Sections of the atrium (A) and ventricular inflow and outlet segment
(VI, VO) of an E10.0 looped mouse embryo heart. The myocardium is positive for muscle actin (brown staining, A and D), while the
endocardium and the AV canal cushions are negative (hematoxylin counterstained). Dark field images in the remaining panels show
detection of TGF2 (B, E) and TGF3 mRNA (C, F). Note the high TGF2 expression in the AV canal myocardium (yellow asterisk) and
the TGF2-positive cells invading the endocardial cushion (yellow arrow) and the dorsal mesocardium (DM). Scale bar in C, 200 m and
in F, 50 m.
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cushion explant cultures (Figs. 1A and 1B; and Fig. 4E,
control), neutralizing TGF2 caused a substantial out-
growth of endocardial cells on the gel surface and the
appearance of some cell–cell separation, but no invasive
mesenchyme within the gel compared to control mouse
AVC explants (Fig. 4E).
Neutralizing antibody to TGF3 caused a profound inhi-
bition of cell transformation in chick explants (Fig. 4D) as
previously reported (Boyer et al., 1999). In contrast, TGF3
antisera had little impact on EMT in mouse (Fig. 4C).
Transformation into mesenchyme was indistinguishable
compared with IgG-treated mouse AV canal explants (Fig. 4E).
In a similar series of experiments, the effects of TGF
inhibition were examined in endocardial cushion explants
derived from the outflow tract regions. Both mouse (Fig. 5E)
and chick (Fig. 5F) outflow tract endocardial cushions
exhibit EMT in the collagen gel assay. An inhibition of cell
transformation was observed with TGF2 blocking antisera
in mouse outflow tract explants (Fig. 5A), but little effect on
cell–cell separation or transformation was observed in
avian outflow tract explants (Fig. 5B). Similar to results
observed in AV canal explants, TGF3 neutralization at-
tenuated EMT in avian, but not to any substantial level in
mouse outflow tract endocardial cushion explants (Figs. 5C
and 5D). Collectively, these data define a functional role for
TGF2 during mammalian endocardial cushion EMT and
demonstrate that TGF3 is not required for transformation
events during this developmental process in mouse devel-
opment (summarized in Table 3).
DISCUSSION
The formation of the four-chambered heart requires pre-
cise interactions among multiple cell types. The high
frequency of congenital heart defects involving abnormal
cardiac valve formation and septation reflects the complex-
ity of these developmental events. Among infants, congeni-
tal heart defects are the largest class of birth defects and
account for one of the three most common causes of death
in the first year of life (Rubin et al., 1985). The relatively
high occurrence and associated costs of congenital heart
defects make a compelling case to better understand the
molecular and cellular basis of heart development.
Distinct Temporal Events in Avian and Mouse
Endocardial Cushion Morphogenesis
Initial progress in understanding development within the
embryonic cardiac AV canal has been advanced with use of
avian heart tissue in a three-dimensional collagen gel cul-
ture system. The ability to study in vitro phenotypic
FIG. 3. Expression of TGF2 and TGF3 in E12.0 mouse embryos. Sections of an E12.0 mouse embryo heart at the level of the inflow of
the left (LV) and right ventricle (RV) showing the four-chamber configuration. In this region of the heart, the actin-positive atrial septum
(AP) and muscular ventricular septum (MVS) separate the atrium (LA, RA) and ventricle (LV, RV) and are both fused to the actin negative
AV cushions (asterisk) (A). TGF2 expression is specific to the central AV endocardial cushion tissue, the myocardium of the AV canal, and
to the forming leaflets of the AV valves (B). TGF3 is expressed in the AV endocardial cushion tissue to a lesser extent, but highly expressed
in the bronchi (B) and common cardinal vein (C). DAo, descending aorta; TW, thoracic wall; CCV, common cardinal vein; LVV, leaflet of
venous valve. Scale bar, 100 m
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changes analogous to in vivo morphogenic events in an
experimental system has led to the current understanding
of molecular events regulating endocardial cushion cell
transformation, differentiation, and invasion. Further
progress has been made by the creation of mouse models
harboring genetic perturbations resulting in cardiac pheno-
types; however, almost all experiments utilizing the three-
dimensional collagen gel assay have been performed by
using AV canal tissue derived from avian embryos. Al-
though Sissman (1970) compiled observations describing
developmental landmarks during cardiac morphogenesis
among several species, no direct detailed comparison be-
tween mouse and chick endocardial cushion morphogen-
esis has been reported.
We and others investigating mouse AV canal formation
have begun using the collagen gel assay to assess transfor-
mation and invasion (Camenisch et al., 2000; Dor et al.,
2001; Lakkis and Epstein, 1998; Mjaatvedt et al., 1998).
Here, we report staging of avian and mouse embryos based
on structure and somite number, which provides the most
accurate comparative measure of endocardial cushion mor-
phogenesis between species. We were able to discern nor-
mal interspecies variations by directly comparing parallel
AV canal explants derived from equivalent somite staged
mouse and chick embryos. Specifically, while cell transfor-
mation and invasion occurs in both mouse and chick AV
canal explants at 26 somites (1), there is an absence of
discernible endothelial cell migration in mouse-explanted
tissue at this stage. In contrast, cardiac endothelium from
comparable chick AV canal explants cultured for 48 h
displays a characteristic spread onto the collagen gel surface
and demonstrates cell–cell separation prior to mesenchy-
mal cell transformation (Runyan and Markwald, 1983).
Utilization of anatomic structure and somite number for
assessing developmental progression will be important for
future investigations of heart septal and valve formation,
particularly for analysis of mutant embryos displaying
complex cardiopathies and growth retardation.
Post-Transformation Events
There is a dramatic change in AV canal explants cultured
from later staged embryos that have already executed
epithelial-to-mesenchymal transformation within the en-
docardial cushions. In both mouse and avian AV explants at
30 somites and greater, an extensive endothelial monolayer
spreads onto the collagen gel surface. Transformation still
occurs, but at a diminished level compared with earlier
stages. This observation suggests that, following in vivo
cushion endothelial cell transformation, there is a shift
toward endothelial expansion and cessation of transforma-
tion. This may reflect increased VEGF levels which appear
to serve a multifactoral role during endocardial cushion
morphogenesis (Dor et al., 2001). VEGF acts as a negative
regulator of transformation and a mitogen for the temporary
expansion of the endothelium to fill gaps vacated by acti-
vated endocardial cells. This activity coincides with dimin-
ished TGF2 expression at E11.5 in the myocardium of the
AV canal (Dickson et al., 1993) and, as we show here, the
detectable expression of TGF3. In this regard, VEGF pro-
tein production is increased by TGF3 in a dose-dependent
manner (Saadeh et al., 2000), suggesting that TGF3 may be
upstream of VEGF as required for terminating transforma-
tion activity. The observed phenotypic similarities in
mouse and chick endocardial cushion tissues following
endothelial cell transformation suggest that both induction
of VEGF and a shift in TGF expression may be required for
successful remodeling of the cushions into differentiated
valvular tissue. Collectively, this direct interspecies com-
parison in the collagen gel invasion assay has defined the
developmental window of endocardial cushion EMT and
revealed distinct temporal variations between avian and
mouse AV canal morphogenetic events.
Temporal Requirement for TGF2 in Mouse
Endocardial Cushion Mesenchyme Formation
In avian models, the peptide growth factors TGF2,
signaling through the Type III TGF receptor, and TGF3,
through the Type II TGF receptor, direct nonredundant
signaling cascades in the developing AV endocardial cush-
ions (Boyer et al., 1999; Boyer and Runyan, 2001; Brown et
al., 1996, 1999). There is a temporal separation for the
requirements for TGF ligand signaling. TGF2 appears to
mediate initial cell–cell separation of activated canal endo-
cardium derived from chick embryos, while TGF3 is
essential for subsequent mesenchymal cell formation and
invasion into the underlying matrix. These data are consis-
tent with a previously proposed model where TGF2 and
TGF3 are sequentially and separately involved in the
process of endocardial cushion transformation during avian
embryogenesis (Boyer et al., 1999). The role of TGFs in
mouse endocardial cushion formation has not been clearly
defined. Nakajima et al. (1997) examined the roles of TGF
molecules and latent TGF binding protein-1 in mouse
AVC cushion explants. Although this investigation did
show that concomitant neutralization of TGF1, TGF2,
and TGF3 reduced mesenchyme formation by 73%, the
study failed to elucidate functional specificity of particular
TGF ligand(s) due to cross-reacting antibodies. Using spe-
cific and defined antibodies to TGF2, we show TGF2
functioning during mouse endocardial cushion EMT.
Our observations that mouse endocardial cells from AV
canal explants do not normally display intermediate cell-
to-cell separation prior to transformation, along with the
differential expression patterns for TGF2 and TGF3 in
the forming cardiac cushions, support an extended and
distinct temporal requirement for TGF2, but not TGF3,
for transformation and invasion events. Although TGF2
and TGF3 are both expressed in the avian cushion myo-
cardium (Boyer et al., 1999), we detect expression of only
TGF2 in the mouse AV canal cushion myocardium at a
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time coincident with endocardial cell transformation
(E9.5) (Fig. 2; and see Fig. 6). The expression of TGF2
persists through the duration of formation of the mitral and
tricuspid valves (data not shown). The observation that
TGF2 is detected in both the cushion myocardium as well
as in transformed mesenchymal cells suggests that it may
serve an autocrine function in addition to its paracrine
pathway (Dickson et al., 1993). In contrast, TGF3 does not
become detectable until post-transformation and invasion
events in the mouse (Figs. 2 and 3). The expression pattern
for TGF3 appears to be more relevant in later stages of
AVC morphogenesis and in major vessel formation (Fig.
3C). This postulate was confirmed by demonstrating a
dependence only on TGF2, independent of TGF3, for
mesenchyme formation in mouse AV canal explants.
These expression and function data examining early EMT
in mouse and chick AVC explants appear to correlate with
mouse embryos deficient for TGF2. Recent detailed ex-
amination of TGF2 knockout mice beyond E14 showed
hypoplasia of the septal contribution of the AV canal
endocardial cushions (Bartram et al., 2001). Such an abnor-
mality results in incomplete endocardial cushion fusion
and ventricular septal defect. Also observed were abnormal
endocardial cushion volume related to delayed myocardial-
ization of the cushions compromised by thickening of the
primitive valve leaflets and retention of a cushion like
FIG. 4. TGF blocking antibody effects on E9.5 mouse and stage 15–16 chick AV canal explant cultures. TGF2 antisera inhibits
mesenchyme formation in mouse AV canal explants (A); in chick explants, TGF2 antisera causes a lack of endothelial cell separation and
decreased mesenchyme (B). Anti-TGF3 antibody-treated mouse AV canal explants (C) are indistinguishable from control mouse explant
cultures (E); in chick AV canal explants, TGF3 antisera has a profound effect on cell transformation, but not cell–cell separation, (D).
Optical section of a control chick explant demonstrates invasive mesenchyme and cell separation in the overlying endothelial sheet (F)
similar to mouse control explants in (E). Scale bar, 40 m.
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appearance in older TGF2/ embryos (E14). These find-
ings suggest endocardial cushion cell differentiation, rather
than physical cushion formation, is perturbed in the ab-
sence of TGF2. However, in the mouse, we and others
(Dickson et al., 1993) show that TGF2 is expressed in the
forming heart prior to AV valve formation and remodeling
TABLE 3
Summary of TGF Ligand Requirements during Mouse and Avian Endocardial Cushion Morphogenesis in Vitro
Condition
Mouse Chick
Activation Transformation Activation Transformation
No treatment N/A*   
TGF2 blocking Ab / 2 2 
TGF3 blocking Ab N/A*   2
Note. , normal;2, inhibited; N/A, not applicable; *, not readily defined in E9.5 mouse endocardial cushion explant cultures applicable;
/, intermediate endocardial cell phenotype.
FIG. 5. TGF blocking antibody effects on outflow tract explant cultures. TGF2 antiserum inhibits cell transformation in mouse outflow tract
cultures (A), but has little effect on cell–cell separation or transformation in avian outflow tract explants (B). In contrast, TGF3 antiserum has
no significant effect on mouse outflow tract cushion explants (C) but causes an inhibition of cell transformation in chick explants (D). Normal
outflow tract endocardial cushion explants are shown for mouse (E, E9.5) and chick (F, stage HH15–HH16). Scale bar, 40 um.
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(summarized in Fig. 6). These data support the hypothesis
that TGF2 is not a sole inducer of morphologic events
during mouse AV canal development, but it is a key
participant. Given that the activin receptor-like kinase 2
(ALK2) has been shown to mediate transformation in endo-
cardial cushions (Lai et al., 2000), it is possible that TGF3
signaling may act cooperatively with other TGF superfam-
ily members, including BMP4 (Winnier et al., 1995) or
BMP2 (Yamagishi et al., 1999), to promote transformation
of cushion endocardium into mesenchyme. In this regard,
BMP2 has very strong and specific expression to the AV
canal myocardium at E9.5 (Lyons et al., 1990); however, in
mouse embryos lacking BMP2 (Zhang and Bradley, 1996),
the heart tube forms in the exocoelomic cavity and not
FIG. 6. Model of expression-function for TGF ligands during AV canal morphogenesis. Pre-EMT, EMT, and post-EMT stages for AV canal
development are sequentially shown from top to bottom. TGF molecules at each stage and tissue are specified by color for both avian and
mouse tissue from this report and those referenced within. Atrial, atrium side of canal; AVC, atrioventricular canal; Vent, ventricle side
of canal; M, myocardium; E, endocardium.
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inside the amniotic cavity, leaving only speculation as to a
direct role for BMP2 during cardiac valve morphogenesis.
The observed differences in temporal expression profiles
and in vitro functional activities for TGF2 and TGF3 are
consistent with a dual requirement for both growth factors
in the developing cardiac endocardial cushions for both
mouse and avian species. Although we have demonstrated
that TGF3 is not required for cushion mesenchyme for-
mation in the mouse, its expression in the endocardial
cushions at and beyond E12 suggests that it is involved in
subsequent valve leaflet remodeling events. These data may
account for the morphological variation between avian and
mammalian valve structures as well as in the outcomes in
the collagen gel assays. The prototypical member of this
growth factor family, TGF1, is more important for regula-
tion of chronic vascular diseases and not cardiovascular
development (Topper, 2000). Although neither TGF1- nor
TGF3-deficient embryos exhibit cardiac phenotypes
(Dickson et al., 1995; Sanford et al., 1997; Taya et al., 1999),
TGF2//TGF3/ compound homozygote embryos dis-
play a more severe cardiac defect phenotype and die earlier
than TGF3/ embryos (M. Azhar and T. Doetschman,
personal communication). Collectively, these observations
indicate cooperative roles for TGF mediators during endo-
cardial cushion formation, transformation, and post-
transformation events, including valve differentiation and
septation.
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